NASDAQ: KURA - Kura Oncology, Inc.

Yield per half year: -61.65%
Dividend yield: 0.00%
Sector: Healthcare

Kura Oncology, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -9.44 -100%
P/S 0 33.77 -100%
P/BV 2.52 4.83 -47.73%
P/FCF -6.25 61 -110.24%
Ev/Ebitda -5.96 -22.17 -73.14%
Ev/S 0 22.57 -100%
Ev/FCF -7.86 68.76 -111.43%
E/P -0.1954 0.0178 -1199.38%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 4.97 -100% 0 0%
ROE -38.42 9.61 -499.72%
ROA -34 0.3443 -9975.83%
ROIC -24.6 7.63 -422.23%
ROS 0 -25.17 -100%
ROCE -41.74 15.45 -370.14%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0657 -3.68 -98.21% -0.0779 -15.68%
Nеt Debt/Ebitda 0.122 -3.44 -103.55%
Debt/Ratio 0.0241 0.1986 -87.84%
Debt/Equity 4.34 1.66 160.79%
Debt/Net Income -0.071 10.32 -100.69%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.541 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 0.9598 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.541

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
0 -57.64 -100%
Growth impulse Ebitda in 5 years 163.67 -90.94 -279.98%
Growth impulse Net Income in 5 years 142.27 -97.8 -245.47%
Growth impulse FCF in 5 years 127.26 -108.72 -217.05%
Growth impulse EPS in 5 years 38.03 -142.05 -126.77%
IP Score
3.68/10

Similar companies

DENTSPLY SIRONA

Alexion

Amgen

ABIOMED

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription